Samir K Shah, MD, MPH

The Low dose ColchicinE in pAtients with peripheral Artery DiseasE to address residual vascular Risk (LEADER-PAD) trial will evaluate if anti-inflammatory therapy with colchicine will reduce vascular events in patients with symptomatic peripheral…

Investigator

Samir K Shah

Status

Accepting Candidates

Ages

18 Years - N/A

Sexes

All

The goal of this clinical trial is to compare the number of catheter-free days (CFD) and the rate and severity of any dialysis access-related infections between the ATEV and AVF groups over 12 months in patients with end-stage renal disease (ESRD)…

Investigator

Samir K Shah

Status

Accepting Candidates

Ages

18 Years - N/A

Sexes

Female

The objective of this prospective, multicenter, randomized, controlled clinical trial is to demonstrate the superiority of the VBX Device for primary patency when compared to bare metal stenting in complex iliac occlusive disease.

Investigator

Samir K Shah

Status

Accepting Candidates

Ages

18 Years - N/A

Sexes

All